N-acetylglucosamine increases symptoms and fungal burden in a murine model of oral candidiasis

作者：Ishijima Sanae A; Hayama Kazumi; Takahashi Miki; Holmes Ann R; Cannon Richard D; Abe Shigeru^*

来源：Medical Mycology, 2012, 50(3): 252-258.

DOI：10.3109/13693786.2011.598194

• N-acetylglucosamine
• oral candidiasis
• murine model
• mucosal infection
• osteoarthritis nutritional therapy

The amino sugar N-acetylglucosamine (GlcNAc) is an in vitro inducer of the hyphal mode of growth of the opportunistic pathogen Candida albicans. The development of hyphae by C. albicans is considered to contribute to the pathogenesis of mucosal oral candidiasis. GlcNAc is also a commonly used nutritional supplement for the self-treatment of conditions such as arthritis. To date, no study has investigated whether ingestion of GlcNAc has an effect on the in vivo growth of C. albicans or the pathogenesis of a C. albicans infection. Using a murine model of oral candidiasis, we have found that administration of GlcNAc, but not glucose, increased oral symptoms of candidiasis and fungal burden. Groups of mice were given GlcNAc in either water or in a viscous carrier, i.e., 1% methylcellulose. There was a dose-dependent relationship between GlcNAc concentration and the severity of oral symptoms. Mice given the highest dose of GlcNAc, 45.2 mM, also showed a significant increase in fungal burden, and increased histological evidence of infection compared to controls given water alone. We propose that ingestion of GlcNAc, as a nutritional supplement, may have an impact on oral health in people susceptible to oral candidiasis.

• 出版日期2012-4
• 单位河北医科大学